Interactive Voice Based Administration of the GAD 7
1 other identifier
interventional
40
1 country
1
Brief Summary
This study investigates a new delivery method for the General Anxiety Disorder - 7 (GAD 7), a clinically accepted tool for diagnosing general anxiety disorder. The new tool records auditory responses to the assessment and the study will examine if the instrument is effective at capturing participant depression levels. If proven effective, future studies may investigate if the new format can be used to improve at home clinical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2021
CompletedFirst Submitted
Initial submission to the registry
July 6, 2021
CompletedFirst Posted
Study publicly available on registry
August 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2022
CompletedApril 21, 2022
April 1, 2022
12 months
July 6, 2021
April 19, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
GAD 7 Diagnostic Scores
Scores from the self administered assessment for general anxiety disorder
Five minutes
User Experience Questionnaire
Likert based questionnaire on user experience
Five minutes
Secondary Outcomes (1)
Patient's Qualitative Responses
One minute
Study Arms (2)
Paper Baseline
EXPERIMENTALHalf of the participants will complete the GAD 7 in the traditional paper format at their first appointment. At their second appointment 1-month later, they will complete the GAD 7 on the Mirror device equipped with Amazon Alexa.
Alexa Baseline
EXPERIMENTALThe other half of the participants will complete the GAD 7 on the Mirror device equipped with Amazon in the traditional paper format at their first appointment. At their second appointment 1-month later, they will complete the GAD 7 in the traditional paper format.
Interventions
The paper based GAD 7 that is commonly accepted at clinics
This is the voice based GAD 7 that is administered through a Mirror device equipped with Amazon Alexa software.
Eligibility Criteria
You may qualify if:
- Newly admitted patients to the Oklahoma State University Behavioral Medicine Clinic
You may not qualify if:
- Vulnerable populations, such as children (i.e., minors or individuals under the legal age of consent) and individuals who are incarcerated (i.e., prisoners), will be excluded.
- Individuals who are not their own guardian (i.e., those suffering from severe disabilities) will also be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
OSU Behavioral Health Clinic
Tulsa, Oklahoma, 75135, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Beaman, D.O.
Oklahoma State University Center for Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2021
First Posted
August 4, 2021
Study Start
June 10, 2021
Primary Completion
May 31, 2022
Study Completion
June 15, 2022
Last Updated
April 21, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share
Aggregate data and findings will be posted on ClinicalTrials.gov.